Related Experiment Video
Updated: Jan 24, 2026

Metabolic Profile Analysis of Zebrafish Embryos
Published on: January 14, 2013
Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD+ Metabolic Plasticity and NAMPT Inhibitor Sensitivity in
Swati Dubey1, Guanqiao Yu1, Ryana Aboul-Hosn1
1Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Abstract:
While CDKN2A loss is classically associated with cell cycle deregulation through the p16-Cdk4-Rb axis, our findings suggest an additional layer of metabolic vulnerability arising from altered NAD homeostasis in CDKN2A-deleted glioblastoma, revealing a previously unrecognized metabolic-genetic interface for rationally revisiting NAD+ targeting strategies, moving beyond the broad inhibition approaches.
Insights
Loss of the CDKN2A gene in glioblastoma creates metabolic vulnerabilities linked to NAD+ homeostasis. This discovery suggests new therapeutic strategies targeting NAD+ metabolism beyond broad inhibition approaches.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer genetics
Background:
- The CDKN2A gene is known to regulate the cell cycle via the p16-Cdk4-Rb pathway.
- CDKN2A loss is a common event in glioblastoma, a highly aggressive brain tumor.
Purpose of the Study:
- To investigate the metabolic consequences of CDKN2A loss in glioblastoma.
- To identify novel therapeutic targets based on altered metabolic pathways in CDKN2A-deleted glioblastoma.
Main Methods:
- Analysis of gene expression and metabolic profiles in glioblastoma samples.
- Investigating the role of NAD+ homeostasis in the context of CDKN2A loss.
Main Results:
- CDKN2A deletion leads to significant alterations in NAD+ homeostasis.
- This metabolic dysregulation presents a vulnerability in CDKN2A-deleted glioblastoma cells.
- A novel link between cell cycle deregulation and metabolic pathways was identified.
Conclusions:
- CDKN2A loss in glioblastoma induces metabolic vulnerabilities related to NAD+ homeostasis.
- Targeting NAD+ metabolism offers a promising therapeutic avenue for CDKN2A-deleted glioblastoma.
- This research opens new avenues for precision medicine in glioblastoma treatment.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
The Citric Acid Cycle
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
What is the Cell Cycle?
What is the Cell Cycle?

